Related Experiment Video
Updated: Jul 14, 2026

Application of Long-term cultured Interferon-γ Enzyme-linked Immunospot Assay for Assessing Effector and Memory T Cell Responses in Cattle
Published on: July 11, 2015
Pharmacokinetics assessment of moxidectin long-acting formulation in cattle
J Dupuy1, J F Sutra, M Alvinerie
1INRA-UR66, Laboratoire de Pharmacologie-Toxicologie, 180 Chemin de Tournefeuille, B.P. 3, 31931 Toulouse Cedex 9, France. Jacques.Dupuy@toulouse.inra.fr
This study evaluated moxidectin pharmacokinetics in cattle using a long-acting (LA) formulation over 120 days. Moxidectin concentrations in plasma and hair were measured, revealing prolonged presence and similar bioavailability compared to other formulations.
Area of Science:
- Veterinary Pharmacology
- Pharmacokinetics
- Drug Disposition
Background:
- Moxidectin is a widely used antiparasitic agent in cattle.
- Understanding the pharmacokinetics of long-acting (LA) formulations is crucial for optimizing treatment efficacy and duration.
- Previous studies have primarily focused on injectable formulations, necessitating research into novel delivery systems.
Purpose of the Study:
- To characterize the plasma and hair disposition of moxidectin following subcutaneous administration of a 10% LA formulation in Charolais cattle.
- To determine key pharmacokinetic parameters, including Cmax, Tmax, MRT, and AUC, in both plasma and hair over a 120-day period.
- To compare the bioavailability of the LA formulation with existing injectable formulations.
Main Methods:
- Subcutaneous administration of moxidectin (1 mg/kg) LA formulation to five Charolais cattle.
- Serial blood and hair sampling for 120 days post-administration.
- Plasma extraction and derivatization followed by HPLC analysis with fluorescence detection for moxidectin quantification.
- Calculation of pharmacokinetic parameters (Cmax, Tmax, MRT, AUC).
Main Results:
- Moxidectin was detected in plasma within 1 hour and in hair within 2 days, with peak concentrations observed at approximately 3.4 days (plasma) and 2 days (hair).
- Mean residence time (MRT) was significantly longer in plasma (28.9 days) than in hair (13.3 days).
- The bioavailability of the LA formulation was comparable to the 0.2 mg/kg subcutaneous injectable formulation, despite a higher dose rate.
Conclusions:
- The 10% LA moxidectin formulation demonstrates prolonged absorption and distribution in cattle, with detectable concentrations in plasma and hair for up to 120 days.
- Moxidectin hair concentrations effectively reflect plasma disposition, suggesting hair analysis as a potential biomarker for drug exposure.
- The extended pharmacokinetic profile of the LA formulation supports its efficacy for sustained parasite control, warranting correlation with clinical efficacy studies.
More Related Videos
Related Concept Videos
Measurement of Bioavailability: Pharmacodynamic Methods
Measurement of Bioavailability: Pharmacokinetic Methods
Modified-Release Drug Delivery Systems: Bioavailability
Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship
Dosage Regimens: Partial Pharmacokinetic Parameters
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation
On...

